Inicio/UNH

Public research page

Market data comes from the live feed. The company research below uses verified public sources, but it is not a real-time personalized AI conclusion.

Analyze UNH in workspace
UNHNYSE/Healthcare

UnitedHealth Group Incorporated

$429.09Up+4,47 (+1,05%)
Research reviewed: 11 jul 2026, 00:00 UTC
Research overview3-month price contextInvestment thesisKey catalystsLatest earnings researchRecent newsData and research sources

Research overview

UnitedHealth Group Incorporated is monitored through the lens of managed care scale and medical cost trend.

Eröffnung
426,47
Hoch
431,55
Tief
425,53
Marktkapitalisierung
389,68 Mrd.
KGV
32.29
52-Wochen-Hoch
--
Dividende
2.190%
Quartalsdividende
--

3-month price context

El gráfico muestra la tendencia reciente de 3 meses para entender la estructura de corto plazo antes de abrir el workspace completo.

Investment thesis

Base case
managed care scale and medical cost trend
Bull case
Optum growth and diversified healthcare services
Bear case
medical cost pressure and policy scrutiny
Thesis invalidation
MLR, Medicare Advantage, regulation, and Optum growth

Key catalysts

  • Medicare repricing

    Trend-driven Medicare Advantage repricing can improve the alignment between premiums and medical costs.

  • Medicaid rate updates

    Medicaid rate updates are supporting Community & State revenue and can partially offset membership pressure.

  • Optum recovery levers

    Specialty-pharmacy growth and operational improvements across Optum provide potential earnings-recovery levers.

Principal risks

  • Membership attrition

    Medicare Advantage and Medicaid membership attrition can reduce premium revenue and volume across UnitedHealthcare and Optum.

  • Elevated medical costs

    Elevated medical costs continue to pressure Optum Health margins and could outpace repricing actions.

  • Investment pressure

    Continued investment in people, technology, and products is weighing on Optum Insight and Optum Rx earnings.

Latest earnings research

2026 Q1

For the quarter ended March 31, 2026, UnitedHealth Group reported performance supported by prior operating actions, while Medicare Advantage and Medicaid membership attrition and elevated Optum Health medical costs remained important pressures.

Valuation interpretation

  • Multiple recovery depends on evidence that repricing and operational improvements are stabilizing medical-cost margins.
  • Persistent membership attrition or elevated care costs would justify a wider uncertainty discount.

Peer research

LLY

Recent news

MT Newswires · vor 5 Stunden

Update: Nasdaq Snaps 3-Day Winning Streak as Oil Jumps Amid US-Iran Tensions

MT Newswires · vor 8 Stunden

Equities Fall Intraday, Oil Soars as Trump Reinstates Iranian Shipping Blockade in Hormuz

Zacks · vor 8 Stunden

Is UNH Stock Worth Buying Ahead of Q2 Earnings? Key Estimates to Watch

Trefis · vor 8 Stunden

The Premium On CVS Stock Vs What Its Peers Deliver

Zacks · vor 9 Stunden

Humana Eyes 3% Medicare Advantage Margin: Can It Deliver?

Zacks · vor 13 Stunden

UnitedHealth (UNH) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Data and research sources

Research updated: 11 jul 2026, 00:00 UTC
3 verified sources
UnitedHealth Group Reports First Quarter 2026 ResultsUnitedHealth Group · earningsVerified

Fetched: 11/7/2026, 0:00:00 UTC

Published: 21/4/2026, 0:00:00

Open original source
UnitedHealth Group Investor RelationsUnitedHealth Group · companyVerified

Fetched: 11/7/2026, 0:00:00 UTC

Open original source
UnitedHealth Group Form 10-Q for the Quarter Ended March 31, 2026UnitedHealth Group · filingVerified

Fetched: 11/7/2026, 0:00:00 UTC

Published: 21/4/2026, 0:00:00

Open original source
UNH editorial research profileAlphaVue Research · editorialVerified

Fetched: 11/7/2026, 0:00:00 UTC

Continue in the research workspace

Keep UNH in context, run a multi-agent analysis, and monitor thesis changes.

Analyze UNH free

Explora todo el sistema de análisis

Cada etapa cumple una función concreta y deja un resultado auditable.

Metodología de análisisLeer informes de mercadoExplorar acciones

Continue researching this stock

Analista de Mercado

Analista de Mercado se especializa en la etapa de Observar dentro de Investigación central y ordena el contexto para los siguientes roles.

Analista Fundamental

Analista Fundamental se especializa en la etapa de Observar dentro de Investigación central y ordena el contexto para los siguientes roles.

Analista de Noticias

Analista de Noticias se especializa en la etapa de Observar dentro de Investigación central y ordena el contexto para los siguientes roles.

Gerente de Riesgo

Gerente de Riesgo se especializa en la etapa de Monitorizar dentro de Riesgo y monitoreo y ordena el contexto para los siguientes roles.